Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameOffice of AIDS Research Advisory CouncilAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number1918
Original Establishment Date6/27/1994Committee StatusChartered
Actual Termination Date Committee URLhttps://www.oar.nih.gov/hiv-policy-and-research...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*28
Current Charter Date6/27/2018Designated Fed Officer Position Title*Supervisory Health Science Administrator
Date Of Renewal Charter6/27/2020Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Jay
Exempt From Renewal*NoDesignated Federal Officer Middle NameR.
Specific Termination AuthorityDesignated Federal Officer Last Name*Radke
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPh.D.
Specific Establishment Authority*42 USC 300cc-40aDesignated Federal Officer Phone*(240) 669-5046
Effective Date Of Authority*6/10/1993Designated Federal Officer Fax*(301) 496-2119
Committee Type*ContinuingDesignated Federal Officer Email*jay.radke@nih.gov
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Office of AIDS Research Advisory Council (OARAC) is composed of highly qualified individuals who possess scientific expertise in AIDS research and a public commitment to advance the AIDS scientific agenda. The Council provides a breadth and balance of specialized knowledge necessary to advise the Director of the Office of AIDS Research (OAR) and the Director of the National Institutes of Health (NIH). The NIH Revitalization Act of 1993 called for the establishment of OARAC to provide advice on planning, coordination, and evaluating AIDS research supported by the NIH and to advise on the awarding of funds from the OAR Discretionary Fund. The OAR depends heavily on the Council's advice in the extensive process of reviewing all NIH AIDS research and developing long-term research plans. To accomplish this, briefing sessions on specific topics that are timely and of relevance were presented during FY 2018 to update the OARAC on:Status of NIAID plans for the DAIDS-sponsored clinical trials networks, due to be re-competed in FY 2019; Status of plans for the MACS and WIHS prospective cohort studies which beginning in FY 2019 the NHLBI will manage awards for as a combined cohort study to focus research priorities on chronic HIV-related comorbidities;Update from NIDA on the domestic opioid crisis and HIV; Updates from OAR staff on trans-NIH cost sharing for funding areas of science that have both HIV/AIDS and non-AIDS-related components;Updates on OAR development of a two-year trans-NIH plan for HIV-related research for FY 2019-20, and plans for multi-year plans after that transitional year (up until now, trans-NIH plans have been prepared annually); Status of the reorganization of AIDS and Related Research (AARR) integrated review group study sections by the CSR;Updates on HIV-related research portfolios of several NIH Institutes, Centers and NIH/OD Offices (NCI, NIA, NICHD, NIMH and OD/ORIP);The Council also advised on the activities of the five HHS HIV/AIDS Treatment Guideline panels of experts in HIV care who, constituted as Working Groups of the OARAC, maintain updated federally approved medical practice guidelines for HIV/AIDS care and treatment.
How is membership balanced?*The OARAC is composed of eighteen authorized members, twelve of whom are authorities in the fields of molecular biology, immunology, virology, neurology, pediatrics, vaccine development, antiviral development, clinical care, animal model research, retrovirology, structural biology, infectious disease, epidemiology, mental health, and substance abuse/addictions sciences. Six public members have expertise in public policy, health policy, economics, and management.
How frequent & relevant are cmte mtgs?*The OARAC meets approximately three times a year and provides advice on a continuing basis on the direction of the NIH AIDS research program, the development and annual review of a comprehensive plan for the conduct and support of all AIDS activities of the agencies of NIH, including direct involvement in budget projections for carrying out the plan which includes an estimate of the number and type of personnel needed for OAR. The Committee conducted three meetings on the following dates: 11/16/2017, 03/27/2018 and 07/12/2018.
Why advice can't be obtained elsewhere?*The committee and membership requirements are specifically addressed in statute. AIDS research is conducted throughout the NIH, which includes 23 institutes and Centers, and 3 NIH OD Offices. The OARAC is the only council with advisory responsibilities applicable to the entire NIH AIDS research program. Therefore, it is essential to the coordination of the NIH AIDS scientific effort and research direction of the agency's AIDS programs.
Why close or partially close meetings?The November 16, 2017 OARAC meeting was partially closed in accordance with section 10(d) of the Federal Advisory Committee Act (FACA) and provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), Title 5 U.S.C. The proposed closed portion of the meeting included the review, discussion, and Council amendment or approval of the recommendations from the Working Groups of the OARAC that update the HHS Treatment and Prevention Guidelines for medical care of people living with HIV in the United States. The premature disclosure of information which would be likely to significantly frustrate implementation of a proposed agency action.
Recommendation RemarksThere were no formal, substantive committee reports made to the Agency, the President, or the Congress in FY 2018.

Members Agosto-Rosario, Diclemente, Gandhi and Kuritzkes were administratively extended until 3/30/2018.

Dr. Raab-Traub was assigned as the National Cancer Advisory Board representative to OARAC as required by the Charter.

In FY 18, Dr. Goodenow, in the DFO capacity, was replaced by Dr. Jay R. Radke, Supervisory Health Science Administrator.

Mary Jane Rotheram-Borus, Ex-officio, was removed by the Exec Sec in FY17 and is no longer on the Council.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionNoAction CommentThe Committee makes recommendations to the federal staff on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the NIH. OARAC also advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all AIDS activities of the agencies of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments which often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*140Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentBriefing sessions on specific topics that are timely and of relevance were presented during FY2018 to update the OARAC on: Update from NIDA on the domestic opioid crisis and HIV; Updates from OAR staff on trans-NIH cost sharing for funding areas of science that have both HIV/AIDS and non-AIDS-related components; Updates on OAR development of a two-year trans-NIH plan for HIV-related research for FY2019-20, and plans for multi-year plans after that transitional year (up until now, trans-NIH plans have been prepared annually); Status of the reorganization of AIDS and Related Research (AARR) integrated review group study sections by the CSR; Updates on HIV-related research portfolios of several NIH Institutes, Centers and NIH/OD Offices (NCI, NIA, NICHD, NIMH and OD/ORIP). The Council also advised on the activities of the five HHS HIV/AIDS Treatment Guideline panels of experts in HIV care who, constituted as Working Groups of the OARAC, maintain updated federally approved medical practice guidelines for HIV/AIDS care and treatment.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback CommentMinutes, oral presentations, and written reports.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. All of the NIH Institutes and Centers sponsor AIDS research. The OARAC is the only council with advisory responsibilities applicable to the entire NIH AIDS research program. Therefore, it is essential to the coordination of the NIH AIDS scientific effort and research direction of the agency’s AIDS programs. At each meeting, the OARAC receives an update on the activities of the five Working Groups. These Working Groups are sponsored under the auspices of the OARAC and are responsible for the development of state-of-the-science federal guidelines for the medical management of HIV disease and its associated coinfections and opportunistic infections in adults, adolescents, and children.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff* Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members* Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs Est. Other Costs Next FY* 
Total Costs$0.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)* Est. Fed Staff Support Next FY* 
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-001617Office of AIDS Research Advisory Council2017
 COM-002405Office of AIDS Research Advisory Council2016
 COM-003773Office of AIDS Research Advisory Council2015
 COM-004720Office of AIDS Research Advisory Council2014
 COM-006285Office of AIDS Research Advisory Council2013
 COM-006613Office of AIDS Research Advisory Council2012
 COM-008359Office of AIDS Research Advisory Council2011
 COM-008741Office of AIDS Research Advisory Council2010
 COM-010350Office of AIDS Research Advisory Council2009
 COM-010719Office of AIDS Research Advisory Council2008
 COM-011868Office of AIDS Research Advisory Council2007
 COM-012831Office of AIDS Research Advisory Council2006
 COM-014043Office of AIDS Research Advisory Council2005
 COM-014490Office of AIDS Research Advisory Council2004
 COM-015920Office of AIDS Research Advisory Council2003
 COM-016476Office of AIDS Research Advisory Council2002
 COM-017990Office of AIDS Research Advisory Council2001
 COM-018699Office of AIDS Research Advisory Council2000
 COM-019819Office of AIDS Research Advisory Council1999
 COM-020404Office of AIDS Research Advisory Council1998
 COM-021591Office of AIDS Research Advisory Council1997
 COM-034713Office of AIDS Research Advisory Council2018